Multikarya Asia Pasifik Raya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multikarya Asia Pasifik Raya Tbk. trades at Rp1,160 (market cap 3.79T, 136.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Multikarya Asia Pasifik Raya Tbk. is far larger — about 22.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Multikarya Asia Pasifik Raya Tbk. is more actively traded (136.3K versus 96.7K). Which is the better fit depends on your goals.
| MKAP | OBAT | |
|---|---|---|
Market Cap | 3.79T | 167.37B |
Volume | 136.3K | 96.7K |
Lot | 1.36K | 967 |
Turnover | 158.11M | 23.82M |
Average Price | 1,160.03 | 246.34 |
Value | 158.11M | 23.82M |
Indicative Equilibrium Price | 1,160 | 248 |
Indicative Equilibrium Volume | 1.22K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multikarya Asia Pasifik Raya Tbk (the Company) was established on May 16, 2002 in Jakarta, Indonesia under the name of PT Mudking Asia Pasifik Raya, herein after, based on Notarial Deed No. 43 of Yunardi, S.H. The Company started its commercial operations in 2002.
Read more on MKAP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →